Aim : to systematize current evidence and analyze the effectiveness of personalized approaches to correcting hemostatic disorders for preventing recurrent pregnancy loss and placenta-mediated complications. Materials and Methods . A systematic search for publications from 1999 to 2025 was conducted in PubMed/MEDLINE, eLibrary, CyberLeninka, DOAJ (for scientific articles) and FIPS (for patent documents) databases. Using combined MeSH queries, 412 records were initially identified. After removing duplicates and performing multi-stage screening, 63 full-text publications were included in the final analysis. Due to clinical and methodological heterogeneity across studies, a qualitative narrative synthesis of the data was performed. Results . Hemostatic dysregulation serves as a universal pathogenetic arm in pregnancy loss, manifesting through chorionic villi microthrombosis and placental dysfunction. The combination of acetylsalicylic acid (ASA) 100–150 mg and prophylactic doses of low-molecular-weight heparins (LMWHs) significantly increases live birth rates in antiphospholipid syndrome. It is emphasized that isolated carriage of thrombophilia gene polymorphisms is not an independent indication for LMWHs; their use is pathogenetically and clinically justified only when combined with additional risk factors, such as verified antiphospholipid syndrome (APS), a history of thrombosis, or multiple pregnancy losses. For primary preeclampsia prevention, ASA efficacy at 150 mg initiated at 11–14 weeks of gestational age is well established. The critical importance of preconception administration of active folates for hyperhomocysteinemia correction is confirmed. Integral monitoring via thrombodynamics enables tracking of trimester-specific coagulation changes and personalizing antithrombotic dosing. Sulodexide and dipyridamole demonstrate clinical potential in improving uteroplacental blood flow in fetoplacental insufficiency. Conclusion . The contemporary management paradigm for these patients requires a shift from empirical regimens to risk stratification and early preconception screening. Optimal clinical strategy is based on evidence-based ASA prescription, strictly differentiated use of LMWHs, folate metabolism correction, and dynamic therapy control using thrombodynamics. The presented data will help minimize iatrogenic complications and define the trajectory for future multicenter studies.
TCTyumen Multidisciplinary Consultative And Diagnostic Center
Tyumen Multidisciplinary Consultative And Diagnostic Center
NHNoyabrsk Noyabrsk Central City Hospital
Noyabrsk Noyabrsk Central City Hospital
+3
The article presents a new model of the process of invasive thyroid interventions performed under sonographic navigation on an outpatient basis following standard algorithm of operation for each member of the technological process: a surgeon, an ultrasound doctor, and a nurse. The algorithm is managed by a checklist in a form of a unified questionnaire with sequential steps for all team members, namely from laying the patient on the operating table until the end of the procedure. With the algorithm implemented, it is possible to significantly minimize the risk of development of perioperative and postoperative complications, as well as improve the efficiency of internal quality control and safety of medical care.